Arbutus Biopharma Corp Net Income
Arbutus Biopharma Corp (ABUS) reported Net Income of -$5.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2026-08-12
CAD
| Period end | Net Income (Loss) Attributable to Parent 12 month |
|---|---|
| 2012-12-31 | 29.79M CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | -9.94M CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | -12.42M CAD 20-F · filed 2013-03-27 |
| 2009-12-31 | -8.75M CAD 20-F · filed 2012-03-27 |
USD
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.14M 10-Q · filed 2026-08-12 | $164.55M 10-Q · filed 2026-08-12 | $160.80M derived: sum of 3 quarters · filed 2026-08-12 | $153.05M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | $169.69M 10-Q · filed 2026-08-12 | $165.94M derived: sum of 2 quarters · filed 2026-08-12 | $158.20M derived: sum of 3 quarters · filed 2026-08-12 | $160.72M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | -$3.76M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-14 | -$11.50M derived: sum of 2 quarters · filed 2026-04-14 | -$8.97M derived: sum of 3 quarters · filed 2026-08-12 | -$33.50M DEF 14A · filed 2026-04-14 | |||
| 2025-09-30 | -$7.74M 10-Q · filed 2025-11-13 | -$5.22M derived: sum of 2 quarters · filed 2026-08-12 | -$29.75M 10-Q · filed 2025-11-13 | -$42.28M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | $2.52M 10-Q · filed 2026-08-12 | -$22.00M 10-Q · filed 2026-08-12 | -$34.53M derived: sum of 3 quarters · filed 2026-08-12 | -$54.25M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | -$24.53M 10-Q · filed 2026-08-12 | -$37.06M derived: sum of 2 quarters · filed 2026-08-12 | -$56.77M derived: sum of 3 quarters · filed 2026-08-12 | -$76.57M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2024-12-31 | -$12.53M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-14 | -$32.25M derived: sum of 2 quarters · filed 2026-04-14 | -$52.05M derived: sum of 3 quarters · filed 2026-04-14 | -$69.92M DEF 14A · filed 2026-04-14 | |||
| 2024-09-30 | -$19.72M 10-Q · filed 2025-11-13 | -$39.51M derived: sum of 2 quarters · filed 2025-11-13 | -$57.39M 10-Q · filed 2025-11-13 | -$76.70M derived: sum of 4 quarters · filed 2026-04-14 | |||
| 2024-06-30 | -$19.80M 10-Q · filed 2025-11-13 | -$37.67M 10-Q · filed 2025-08-06 | -$56.98M derived: sum of 3 quarters · filed 2026-04-14 | -$77.09M derived: sum of 4 quarters · filed 2026-04-14 | |||
| 2024-03-31 | -$17.88M 10-Q · filed 2025-11-13 | -$37.19M derived: sum of 2 quarters · filed 2026-04-14 | -$57.29M derived: sum of 3 quarters · filed 2026-04-14 | -$74.39M derived: sum of 4 quarters · filed 2026-04-14 | |||
| 2023-12-31 | -$19.31M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-14 | -$39.42M derived: sum of 2 quarters · filed 2026-04-14 | -$56.51M derived: sum of 3 quarters · filed 2026-04-14 | -$72.85M DEF 14A · filed 2026-04-14 | |||
| 2023-09-30 | -$20.10M 10-Q · filed 2024-11-06 | -$37.20M derived: sum of 2 quarters · filed 2024-11-06 | -$53.54M 10-Q · filed 2024-11-06 | -$75.47M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | -$17.09M 10-Q · filed 2024-11-06 | -$33.43M 10-Q · filed 2024-08-08 | -$55.37M derived: sum of 3 quarters · filed 2024-11-06 | -$72.93M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-03-31 | -$16.34M 10-Q · filed 2024-11-06 | -$38.27M derived: sum of 2 quarters · filed 2024-11-06 | -$55.84M derived: sum of 3 quarters · filed 2024-11-06 | -$70.03M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2022-12-31 | -$21.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$39.50M derived: sum of 2 quarters · filed 2024-03-05 | -$53.69M derived: sum of 3 quarters · filed 2024-03-05 | -$69.46M 10-K · filed 2024-03-05 | |||
| 2022-09-30 | -$17.57M 10-Q · filed 2023-11-07 | -$31.76M derived: sum of 2 quarters · filed 2023-11-07 | -$47.52M 10-Q · filed 2023-11-07 | -$68.84M derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2022-06-30 | -$14.19M 10-Q · filed 2023-11-07 | -$29.96M 10-Q · filed 2023-08-03 | -$51.28M derived: sum of 3 quarters · filed 2023-11-07 | -$70.44M derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2022-03-31 | -$15.77M 10-Q · filed 2023-11-07 | -$37.09M derived: sum of 2 quarters · filed 2023-11-07 | -$56.24M derived: sum of 3 quarters · filed 2023-11-07 | -$75.63M derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2021-12-31 | -$21.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$40.48M derived: sum of 2 quarters · filed 2023-03-02 | -$59.87M derived: sum of 3 quarters · filed 2023-03-02 | -$76.25M 10-K · filed 2023-03-02 | |||
| 2021-09-30 | -$19.16M 10-Q · filed 2022-11-09 | -$38.55M derived: sum of 2 quarters · filed 2022-11-09 | -$54.93M 10-Q · filed 2022-11-09 | -$71.97M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | -$19.39M 10-Q · filed 2022-11-09 | -$35.77M 10-Q · filed 2022-08-04 | -$52.81M derived: sum of 3 quarters · filed 2022-11-09 | -$71.56M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-03-31 | -$16.38M 10-Q · filed 2022-11-09 | -$33.42M derived: sum of 2 quarters · filed 2022-11-09 | -$52.18M derived: sum of 3 quarters · filed 2022-11-09 | -$66.27M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2020-12-31 | -$17.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$35.80M derived: sum of 2 quarters · filed 2022-03-03 | -$49.88M derived: sum of 3 quarters · filed 2022-03-03 | -$63.74M 10-K · filed 2022-03-03 | |||
| 2020-09-30 | -$18.75M 10-Q · filed 2021-11-04 | -$32.84M derived: sum of 2 quarters · filed 2021-11-04 | -$46.70M 10-Q · filed 2021-11-04 | -$71.36M derived: sum of 4 quarters · filed 2021-11-04 | |||
| 2020-06-30 | -$14.09M 10-Q · filed 2021-11-04 | -$27.95M 10-Q · filed 2021-08-05 | -$52.60M derived: sum of 3 quarters · filed 2021-11-04 | -$135.10M derived: sum of 4 quarters · filed 2021-11-04 | |||
| 2020-03-31 | -$13.86M 10-Q · filed 2021-11-04 | -$38.52M derived: sum of 2 quarters · filed 2021-11-04 | -$121.02M derived: sum of 3 quarters · filed 2021-11-04 | -$144.33M derived: sum of 4 quarters · filed 2021-11-04 | |||
| 2019-12-31 | -$24.65M 10-K · filed 2020-03-05 | -$107.16M derived: sum of 2 quarters · filed 2020-11-05 | -$130.47M derived: sum of 3 quarters · filed 2020-11-05 | -$153.72M 10-K · filed 2021-03-04 | |||
| 2019-09-30 | -$82.50M 10-Q · filed 2020-11-05 | -$105.82M derived: sum of 2 quarters · filed 2020-11-05 | -$129.07M 10-Q · filed 2020-11-05 | -$147.32M derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2019-06-30 | -$23.32M 10-Q · filed 2020-11-05 | -$46.57M 10-Q · filed 2020-08-07 | -$64.81M derived: sum of 3 quarters · filed 2020-11-05 | -$89.29M derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2019-03-31 | -$23.25M 10-Q · filed 2020-11-05 | -$41.50M derived: sum of 2 quarters · filed 2020-11-05 | -$65.97M derived: sum of 3 quarters · filed 2020-11-05 | -$62.88M derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2018-12-31 | -$18.25M 10-K · filed 2020-03-05 | -$42.72M derived: sum of 2 quarters · filed 2020-03-05 | -$39.63M derived: sum of 3 quarters · filed 2020-03-05 | -$57.06M 10-K · filed 2020-03-05 | |||
| 2018-09-30 | -$24.47M 10-Q · filed 2019-11-06 | -$21.38M derived: sum of 2 quarters · filed 2020-03-05 | -$24.47M 10-K · filed 2020-03-05 | -$38.81M 10-Q · filed 2018-11-07 | -$74.74M derived: sum of 4 quarters · filed 2020-03-05 | ||
| 2018-06-30 | $3.09M 10-K · filed 2020-03-05 | -$14.34M 10-Q · filed 2019-08-05 | -$50.27M derived: sum of 3 quarters · filed 2020-03-05 | -$61.87M derived: sum of 4 quarters · filed 2020-03-05 | |||
| 2018-03-31 | -$17.43M 10-K · filed 2020-03-05 | -$53.36M derived: sum of 2 quarters · filed 2020-03-05 | -$64.96M derived: sum of 3 quarters · filed 2020-03-05 | -$83.22M derived: sum of 4 quarters · filed 2020-03-05 | |||
| 2017-12-31 | -$35.93M 10-K · filed 2019-03-07 | -$36.84M 10-K · filed 2018-03-16 | -$47.53M derived: sum of 2 quarters · filed 2019-03-07 | -$65.79M derived: sum of 3 quarters · filed 2019-03-07 | -$84.41M 10-K · filed 2019-03-07 | ||
| 2017-09-30 | -$11.60M 10-K · filed 2019-03-07 | -$29.86M derived: sum of 2 quarters · filed 2019-03-07 | -$48.48M 10-Q · filed 2018-11-07 | -$267.18M derived: sum of 4 quarters · filed 2019-03-07 | |||
| 2017-06-30 | -$18.25M 10-K · filed 2019-03-07 | -$36.88M 10-Q · filed 2018-08-03 | -$255.58M derived: sum of 3 quarters · filed 2019-03-07 | -$275.17M derived: sum of 4 quarters · filed 2019-03-07 | |||
| 2017-03-31 | -$18.63M 10-K · filed 2019-03-07 | -$237.32M derived: sum of 2 quarters · filed 2019-03-07 | -$256.92M derived: sum of 3 quarters · filed 2019-03-07 | -$386.92M derived: sum of 4 quarters · filed 2019-03-07 | |||
| 2016-12-31 | -$218.69M 10-K · filed 2018-03-16 | -$238.29M derived: sum of 2 quarters · filed 2018-03-16 | -$368.29M derived: sum of 3 quarters · filed 2018-03-16 | -$384.16M 10-K · filed 2018-03-16 | |||
| 2016-09-30 | -$19.59M 10-K · filed 2018-03-16 | -$149.59M derived: sum of 2 quarters · filed 2018-03-16 | -$165.47M 10-Q · filed 2017-11-02 | -$170.73M derived: sum of 4 quarters · filed 2018-03-16 | |||
| 2016-06-30 | -$130.00M 10-K · filed 2018-03-16 | -$145.87M 10-Q · filed 2017-08-03 | -$151.14M derived: sum of 3 quarters · filed 2018-03-16 | -$180.12M derived: sum of 4 quarters · filed 2018-03-16 | |||
| 2016-03-31 | -$15.87M 10-K · filed 2018-03-16 | -$21.14M derived: sum of 2 quarters · filed 2018-03-16 | -$50.12M derived: sum of 3 quarters · filed 2018-03-16 | -$65.01M derived: sum of 4 quarters · filed 2018-03-16 | |||
| 2015-12-31 | -$5.26M 10-K · filed 2017-03-22 | -$34.25M derived: sum of 2 quarters · filed 2017-03-22 | -$49.13M derived: sum of 3 quarters · filed 2017-03-22 | -$62.72M 10-K · filed 2018-03-16 | -$61.12M 10-K · filed 2016-03-09 | ||
| 2015-09-30 | -$28.98M 10-K · filed 2017-03-22 | -$43.87M derived: sum of 2 quarters · filed 2017-03-22 | -$55.86M 10-Q · filed 2016-11-03 | -$62.02M derived: sum of 4 quarters · filed 2017-03-22 | |||
| 2015-06-30 | -$14.89M 10-K · filed 2017-03-22 | -$26.88M 10-Q · filed 2016-08-04 | -$33.04M derived: sum of 3 quarters · filed 2017-03-22 | -$41.65M derived: sum of 4 quarters · filed 2017-03-22 | |||
| 2015-03-31 | -$11.99M 10-K · filed 2017-03-22 | -$18.16M derived: sum of 2 quarters · filed 2017-03-22 | -$26.76M derived: sum of 3 quarters · filed 2017-03-22 | -$32.84M derived: sum of 4 quarters · filed 2017-03-22 | |||
| 2014-12-31 | -$6.17M 10-K · filed 2016-03-09 | -$14.77M derived: sum of 2 quarters · filed 2016-03-09 | -$20.85M derived: sum of 3 quarters · filed 2016-03-09 | -$38.84M 10-K · filed 2017-03-22 | |||
| 2014-09-30 | -$8.60M 10-K · filed 2016-03-09 | -$14.69M derived: sum of 2 quarters · filed 2016-03-09 | -$32.67M 10-Q · filed 2015-11-05 | -$35.27M derived: sum of 4 quarters · filed 2016-03-09 | |||
| 2014-06-30 | -$6.08M 10-K · filed 2016-03-09 | -$24.07M 10-Q · filed 2015-08-07 | -$26.66M derived: sum of 3 quarters · filed 2016-03-09 | -$32.57M derived: sum of 4 quarters · filed 2016-03-09 | |||
| 2014-03-31 | -$17.98M 10-K · filed 2016-03-09 | -$20.58M derived: sum of 2 quarters · filed 2016-03-09 | -$26.49M derived: sum of 3 quarters · filed 2016-03-09 | -$29.50M derived: sum of 4 quarters · filed 2016-03-09 | |||
| 2013-12-31 | -$2.60M 10-K · filed 2015-03-13 | -$8.50M derived: sum of 2 quarters · filed 2015-03-13 | -$11.52M derived: sum of 3 quarters · filed 2015-03-13 | -$14.06M 10-K · filed 2016-03-09 | -$14.06M 6-K · filed 2014-03-06 | ||
| 2013-09-30 | -$5.91M 10-K · filed 2015-03-13 | -$5.91M 10-Q · filed 2014-11-07 | -$8.92M derived: sum of 2 quarters · filed 2015-03-13 | -$11.46M 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | -$3.02M 10-K · filed 2015-03-13 | -$3.01M 10-Q · filed 2014-08-14 | -$5.56M 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | -$2.55M 10-K · filed 2015-03-13 | ||||||
| 2012-12-31 | $29.61M 10-K · filed 2015-03-13 | $29.61M 6-K · filed 2014-03-06 | |||||
| 2011-12-31 | -$10.08M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |